levofloxacin has been researched along with d-alpha tocopherol in 5 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (d-alpha tocopherol) | Trials (d-alpha tocopherol) | Recent Studies (post-2010) (d-alpha tocopherol) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 32,198 | 2,903 | 7,258 |
Protein | Taxonomy | levofloxacin (IC50) | d-alpha tocopherol (IC50) |
---|---|---|---|
Glutathione S-transferase P | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gibbons, S; Kaatz, GW; Zloh, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cheow, WS; Hadinoto, K | 1 |
Chauhan, A; Colaço, R; Paradiso, P; Saramago, B; Serro, AP | 1 |
1 review(s) available for levofloxacin and d-alpha tocopherol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for levofloxacin and d-alpha tocopherol
Article | Year |
---|---|
Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cell Membrane; Drug Resistance, Microbial; Drug Resistance, Multiple; Ligands; Models, Molecular | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Drug Stability; Lactic Acid; Levofloxacin; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Ofloxacin; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Surface-Active Agents; Vitamin E; Water | 2011 |
Controlled Release of Antibiotics From Vitamin E-Loaded Silicone-Hydrogel Contact Lenses.
Topics: Anti-Bacterial Agents; Chlorhexidine; Contact Lenses, Hydrophilic; Delayed-Action Preparations; Diffusion; Drug Delivery Systems; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Keratitis; Levofloxacin; Ophthalmic Solutions; Silicones; Vitamin E | 2016 |